![Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug - ScienceDirect Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2056989022004133-e-77-00101-scheme1.jpg)
Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug - ScienceDirect
EDITORIAL - Facts and Figures for the Chemical Process Industries | Industrial & Engineering Chemistry
![Professor Xiaolong Yang from School of Pharmaceutical Sciences published research results in the respected journal Chemical Science-药学院E Professor Xiaolong Yang from School of Pharmaceutical Sciences published research results in the respected journal Chemical Science-药学院E](https://www.scuec.edu.cn/__local/F/5B/19/108EAD6D5F764C29230A15C46CB_065CE583_3B3E3.png?e=.png)
Professor Xiaolong Yang from School of Pharmaceutical Sciences published research results in the respected journal Chemical Science-药学院E
![Molecules | Free Full-Text | Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present) Molecules | Free Full-Text | Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)](https://pub.mdpi-res.com/molecules/molecules-25-02666/article_deploy/html/images/molecules-25-02666-g013.png?1591798283)
Molecules | Free Full-Text | Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)
![Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate - ScienceDirect Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523420301410-fx1.jpg)
Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate - ScienceDirect
![Combined Metabolic and Chemical (CoMetChem) Labeling Using Stable Isotopes – a Strategy to Reveal Site-Specific Histone Acetylation and Deacetylation Rates by LC-MS | Analytical Chemistry | ChemRxiv | Cambridge Open Engage Combined Metabolic and Chemical (CoMetChem) Labeling Using Stable Isotopes – a Strategy to Reveal Site-Specific Histone Acetylation and Deacetylation Rates by LC-MS | Analytical Chemistry | ChemRxiv | Cambridge Open Engage](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c75587842e654540db431e/largeThumb/combined-metabolic-and-chemical-co-met-chem-labeling-using-stable-isotopes-a-strategy-to-reveal-site-specific-histone-acetylation-and-deacetylation-rates-by-lc-ms.jpg)
Combined Metabolic and Chemical (CoMetChem) Labeling Using Stable Isotopes – a Strategy to Reveal Site-Specific Histone Acetylation and Deacetylation Rates by LC-MS | Analytical Chemistry | ChemRxiv | Cambridge Open Engage
![QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase - ScienceDirect QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405844021015668-gr2.jpg)